Feed MAZE
MA
Maze Therapeutics, Inc.
MAZE · NASDAQ
$27.67 -1.23% (-$0.35)
1M -5.85%
Market Cap $1.5B
P/E Ratio -
Div. Yield -
ROE 41.12%
Valuation
46 /100
Fair P/B 4.31x
P/FCF N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 51.82%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 33.02%
ROIC 37.67%
Debt
100 /100
Low Current ratio 15.50x
Debt/Equity 0.07x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 2,355.06%
Profitable years 0
Beta 2.14x
Întreabă StockBot despre MAZE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Coloma
Employees
141
Headquarters
South San Francisco
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report